{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:10:23Z","timestamp":1785755423629,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer US","isbn-type":[{"value":"9781071613573","type":"print"},{"value":"9781071613580","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1358-0_4","type":"book-chapter","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:08:14Z","timestamp":1620774494000},"page":"59-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterizationharacterization of Extremophilic Actinomycetes Strains as Sources of Antimicrobial Agents"],"prefix":"10.1007","author":[{"given":"Diyora","family":"Abdukhakimova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhannur","family":"Markhametova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikal","family":"Shamkeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainur","family":"Zhulamanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Trenozhnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Berezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azliyati","family":"Azizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","unstructured":"Dortmans JC, Koch G, Rottier PJ, Peeters BP (2011) Virulence of Newcastle disease virus: what is known so far? Vet Res. https:\/\/doi.org\/10.1186\/1297-9716-42-122","DOI":"10.1186\/1297-9716-42-122"},{"key":"4_CR2","doi-asserted-by":"crossref","unstructured":"Berezin V, Abdukhakimova D, Trenozhnikova L, Bogoyavlenskiy A, Turmagambetova A, Issanov A, Azizan A (2019) Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan\u2019s unique ecosystems against influenza viruses and paramyxoviruses. Virol J 16(150)","DOI":"10.1186\/s12985-019-1254-1"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S2221-1691(13)60092-1","volume":"3","author":"G Gebreyohannes","year":"2013","unstructured":"Gebreyohannes G, Moges F, Sahile S, Raja N (2013) Isolation and characterization of potential antibiotic producing actinomycetes from water and sediments of Lake Tana, Ethiopia. Asian Pac J Trop Biomed 3:425\u2013435. https:\/\/doi.org\/10.1016\/S2221-1691(13)60092-1","journal-title":"Asian Pac J Trop Biomed"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1046\/j.1365-2672.2003.02049.x","volume":"95","author":"A Basilio","year":"2003","unstructured":"Basilio A, Gonzalez I, Vicente MF et al (2003) Patterns of antimicrobial activities from soil actinomycetes isolated under different conditions of pH and salinity. J Appl Microbiol 95:814\u2013823. https:\/\/doi.org\/10.1046\/j.1365-2672.2003.02049.x","journal-title":"J Appl Microbiol"},{"key":"4_CR5","doi-asserted-by":"publisher","unstructured":"Roberts J, Trenozhnikova L, Seatgon L et al (2013) Bacterial growth in media mimicking the high salt and alkalinity of extreme Kazakhstan environments results in production of antimicrobial compounds in soil actinomycetes isolated from these extremophile locations. J Pharm Technol Drug Res. https:\/\/doi.org\/10.7243\/2050-120X-2-14","DOI":"10.7243\/2050-120X-2-14"},{"key":"4_CR6","doi-asserted-by":"publisher","unstructured":"Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T (2006) Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Res. https:\/\/doi.org\/10.1016\/j.virusres.2006.03.012","DOI":"10.1016\/j.virusres.2006.03.012"},{"key":"4_CR7","doi-asserted-by":"publisher","unstructured":"Takahashi Y, Nakashima T (2018) Actinomycetes, an inexhaustible source of naturally occurring antibiotics. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics7020045","DOI":"10.3390\/antibiotics7020045"},{"key":"4_CR8","doi-asserted-by":"publisher","unstructured":"Jakubiec-Krze\u015bniak K, Rajnisz-Mateusiak A, Guspiel A, Ziemska J, Solecka J (2018) Secondary metabolites of actinomycetes and their antibacterial, antifungal and antiviral properties. Pol J Microbiol. https:\/\/doi.org\/10.21307\/pjm-2018-048","DOI":"10.21307\/pjm-2018-048"},{"key":"4_CR9","doi-asserted-by":"publisher","unstructured":"Chiba H, Inokoshi J, Nakashima H, Omura S, Tanaka H (2004) Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2004.02.036","DOI":"10.1016\/j.bbrc.2004.02.036"},{"key":"4_CR10","doi-asserted-by":"publisher","unstructured":"Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. https:\/\/doi.org\/10.1155\/2016\/2475067. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4871955\/#","DOI":"10.1155\/2016\/2475067"},{"key":"4_CR11","doi-asserted-by":"crossref","unstructured":"Trenozhnikova L, Azizan A (2018) Discovery of Actinomycetes from extreme environments with potential to produce novel antibiotics. Cent Asian J Glob Health 7. http:\/\/cajgh.pitt.edu\/ojs\/index.php\/cajgh\/article\/view\/337\/262","DOI":"10.5195\/cajgh.2018.337"},{"key":"4_CR12","doi-asserted-by":"publisher","unstructured":"Trenozhnikova L, Khasenova AK, Balgimbayeva AS et al (2012) Characterization of the antibiotic compound no. 70 produced by Streptomyces sp. IMV-70. Sci World J 2012. https:\/\/doi.org\/10.1100\/2012\/594231","DOI":"10.1100\/2012\/594231"},{"key":"4_CR13","volume-title":"Identification of Actinomycetes","author":"GF Gauze","year":"1983","unstructured":"Gauze GF, Preobrazhenskaya TP, Terekhova LP, Maksimova TS (1983) Identification of Actinomycetes. Nauka, Moscow"},{"key":"4_CR14","doi-asserted-by":"publisher","unstructured":"Spalatin J, Hanson RP, Beard PD (1970) The haemagglutination-elution pattern as a marker in characterizing Newcastle disease virus. Avian Dis. https:\/\/doi.org\/10.2307\/1588616","DOI":"10.2307\/1588616"},{"key":"4_CR15","doi-asserted-by":"publisher","unstructured":"Klimov A, Balish A, Veguilla V, Sun H, Schiffer J, Lu X, Katz JM, Hancock K (2012) Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol. https:\/\/doi.org\/10.1007\/978-1-61779-621-0_3","DOI":"10.1007\/978-1-61779-621-0_3"},{"key":"4_CR16","doi-asserted-by":"publisher","unstructured":"Jonges M, Liu WM, der Vries E, van der Vries E, Jacobi R, Pronk I, Boog C, Koopmans M, Meijer A, Soethout E (2010) Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.02045-09","DOI":"10.1128\/JCM.02045-09"},{"issue":"6","key":"4_CR17","first-page":"260","volume":"3","author":"AF Li","year":"2009","unstructured":"Li AF, Wang WH, Xu WF, Gong JZ (2009) A microplate-based screening assay for neuraminidase inhibitors. Drug Discov Ther 3(6):260\u2013265","journal-title":"Drug Discov Ther"},{"key":"4_CR18","first-page":"350","volume-title":"Guidelines for preclinical drug research. Part one","author":"AN Mironova","year":"2012","unstructured":"Mironova AN (2012) Guidelines for preclinical drug research. Part one. Grief and K, Moscow, p 350"},{"key":"4_CR19","first-page":"150","volume-title":"Methodological issues of scientific development of antiviral drugs","author":"MA Schneider","year":"1977","unstructured":"Schneider MA (1977) Methodological issues of scientific development of antiviral drugs. Science, Minsk, p 150"}],"container-title":["Methods in Molecular Biology","Antimicrobial Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1358-0_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T05:10:06Z","timestamp":1632805806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1358-0_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071613573","9781071613580"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1358-0_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"12 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}